Konferenzen  >  Medizin & Gesundheitswesen  >  Translationale Medizin, Klinische Studien

Deutsche Gesellschaft für Radioonkologie e. V.

Auf dem Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO) haben alle Fachkollegen/innen der DEGRO Gelegenheit, alle für die Entwicklung der Radioonkologie wichtigen Aspekte in konzentrierter Form zu diskutieren und: so zu einem breiten Erkenntnisaustausch zu kommen. Herausragende Forschungsleistungen werden auf diesem Kongress durch Wissenschaftspreise ausgezeichnet. An diesem Kongress sind auch die Angehörigen der in der Radioonkologie tätigen weiteren Berufsgruppen der MTRA (VMTRO), der Pflegenden in der Radioonkologie (BVPRO), der Medizinischen Fachangestellten in der Radioonkologie (MFAaBRO) und der Officeberufe (OVIRO) aktiv beteiligt.

Die Programmschwerpunkte des DEGRO-Kongress 2023 sind: Neue Technologien – neue Dosiskonzepte | High Tech – High Care: Der Patient im Mittelpunkt | Digitalisierung und Artificial Intelligence | Radio-Immuntherapie, Radio-Chemotherapie or what? | Arbeit im multiprofessionellen Team.

Kongressorganisation;     Tel.: [+49 3643 2468-0];     Email: degro@kukm.de

Radioonkologie, Onkologie, Radiotherapie, Medizinphysik, Strahlenbiologie, Radioimmuntherapie, Radiochemotherapie, Digitalisierung, AI, Patientenzentrierung

Onkologie,    Radiologie, Nuklearmedizin und Radiotherapie

Onkologie,    Pharmakogenomik, Personalisierte Medizin

ESMO - European Society for Medical Oncology

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology will welcome delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

MAP Congress Team;     Tel.: [+41919731947];     Email: map@esmo.org

oncology, personalised medicine, precision medicine, translational research, molecular characterisation, clonal evolution, cancer profiling, metastatic dissemination, biomarkers, targeted therapeutics

Onkologie,    Pharmakogenomik, Personalisierte Medizin

ESMO - European Society for Medical Oncology

The ESMO Asia Congress 2023 will welcome you in Singapore from 1 to 3 December, to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level, and for the Asia-Pacific region. The outstanding scientific programme will cover the latest advances on the most prevalent cancer types in the region, offering high quality multidisciplinary educational sessions and special sessions in collaboration with illustrious international and Asia-Pacific oncology associations.

As usual, there will be a special focus on the Pan-Asian Guidelines Adaptation (PAGA) Lectures, conceived to share best practice standards of care for cancer patients and providing a framework for the structured interaction of key opinion leaders in oncology from Asia and Europe.

We hope you will be part of that journey by attending ESMO Asia 2023, where we will unite the Asian and global oncology community and share unforgettable moments!

Email: asiacongress@esmo.org

Breast cancer, CNS, Developmental and precision medicine, gastrointestinal tumours, genitourinary tumours, gynaecological malignancies, head and neck cancer, investigational immunotherapy, melanoma, public policy, sarcoma, rare tumours, thoracic cancer, oncology

Onkologie,    Pharmakogenomik, Personalisierte Medizin